OROPHARYNGEAL CANCER

This adverse event was reported 208 times

These drugs are most commonly taken by patients reporting OROPHARYNGEAL CANCER:

# Drug Count
0 CISPLATIN 24
1 DEXAMETHASONE 21
2 DEXAMETHASONE 1.5 MG 21
3 ONDANSETRON 19
4 ONDANSETRON HYDROCHLORIDE 19
5 RANITIDINE 12
6 ADALIMUMAB 7
7 METHOTREXATE SODIUM 7
8 RANITIDINE HYDROCHLORIDE 7
9 ETANERCEPT 6
See all common drugs associated with OROPHARYNGEAL CANCER

OROPHARYNGEAL CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM FLUORIDE1.1%, POTASSIUM NITRATE 5% 1 0.5000
1 MIGALASTAT HYDROCHLORIDE 1 0.0018
2 BEDAQUILINE FUMARATE 1 0.0007
3 PROPYLTHIOURACIL 1 0.0005
4 BREXUCABTAGENE AUTOLEUCEL 1 0.0005
5 ZICONOTIDE ACETATE 1 0.0004
6 DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE 1 0.0004
7 CISPLATIN 24 0.0003
8 INFLIXIMAB-DYYB 1 0.0003
9 SCOPOLAMINE 1 0.0003
See all drugs enriched for association with OROPHARYNGEAL CANCER